Tivicay
Active substance: dolutegravir
dolutegravir
Centralised EU authorisationActive
Marketing holder: ViiV Healthcare BV
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 3
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 14 |
|
| US 8 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-4a24-727d-8f1d-7518ca7187a9,01a120c3-5b8e-7b2f-8cfc-1a5b4a988ace,01a120c3-65de-74fc-9e26-76cc4042d138,01a120c3-77fb-74ee-86b1-b91e01a573ba,01a120c3-8d58-71b5-bacb-476c1c37f98b;count=10 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-6580-73f3-b887-066689c981f6,01a1208c-6584-733a-b56b-107b07f2377c,01a1208e-554d-76c7-a8ac-2ef34e4f483a,01a12098-a126-708a-97ae-3c339b598fea,01a12098-e860-730c-b9e9-8c989f016acf;count=5 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- EMEA/H/C/002753
- Registration status
- Active
- ATC code
- J05AX12
- product · EMA · EMEA/H/C/002753 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/002753 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/002753 · Verified 2026-10-09